SCHEMBL4562292

SCHEMBL4562292

N#Cc1cccc(S(=O)(=O)N2CC(CN3CCCC3)Oc3ccc(NC(=O)c4cccc(Cl)c4F)cc32)c1

nearest known ligand 0.67

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
RORC P51449 20/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15611076 0.90 RORC (0.83) RORC
SCHEMBL15611075 0.90 RORC (0.83) RORC
SCHEMBL4566365 0.81 RORC (0.79) RORC
SCHEMBL15625847 0.81 RORC (0.90) RORC
SCHEMBL5022488 0.80 RORC (1.00) RORC
SCHEMBL15610937 0.80 RORC (1.00) RORC
SCHEMBL15625843 0.80 RORC (1.00) RORC
SCHEMBL4562430 0.80 RORC (0.57) RORC
SCHEMBL5023721 0.79 RORC (0.65) RORC
SCHEMBL15625863 0.79 RORC (0.85) RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2638014-A2 TETRAHYDROQUINOLINE AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF ROR ACTIVITY AND THE TREATMENT OF DISEASE Lycera Corporation (US) 2013-09-18 EP disclosed
WO-2012064744-A2 TETRAHYDROQUINOLINE AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORϒ ACTIVITY AND THE TREATMENT OF DISEASE LYCERA CORPORATION (US) 2012-05-18 WO disclosed